Manipulating immune checkpoint signalling pathways with antibodies by Paluch, C

Immune checkpoints as therapeutic targets in autoimmunity by Paluch, C, Santos, A, Anzilotti, C, Cornall, R, Davis, S

Combination CD200R/PD-1 blockade in a humanised mouse model by Fellermeyer, M, Anzilotti, C, Paluch, C, Cornall, RJ, Davis, SJ, Gileadi, U

Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation. by Dos Santos, S, Sheldon, H, Pereira, J, Paluch, C, Bridges, E, El-Cheikh, M, Harris, A, Bernardes, E

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis by Quinn, J, Salman, A, Paluch, C, Jackson-Wood, M, McClements, ME, Luo, J, Davis, SJ, Cornall, RJ, MacLaren, RE, Dendrou, CA, Xue, K

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases by Lippert, AH, Paluch, C, Gaglioni, M, Vuong, MT, McColl, J, Jenkins, E, Fellermeyer, M, Clarke, J, Sharma, S, Moreira da Silva, S, Akkaya, B, Anzilotti, C, Morgan, SH, Jessup, CF, Koerbel, M, Gileadi, U, Leitner, J, Knox, R, Chirifu, M, Huo, J, Yu, S, Ashman, N, Lui, Y, Wilkinson, I, Attfield, KE, Fugger, L, Robertson, NJ, Lynch, CJ, Murray, L, Steinberger, P, Santos, AM, Lee, SF, Cornall, RJ, Klenerman, D, Davis, SJ